294 related articles for article (PubMed ID: 35566712)
1. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
[TBL] [Abstract][Full Text] [Related]
2. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
4. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
Bainbridge HE; Menten MJ; Fast MF; Nill S; Oelfke U; McDonald F
Radiother Oncol; 2017 Nov; 125(2):280-285. PubMed ID: 28987747
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of glioblastoma radiotherapy treatment plans on a low-field MRI-guided linear accelerator compared to conventional C-arm linear accelerator.
Moats E; Siddiqui MS; Parikh P; Snyder KC
Med Dosim; 2024 Jan; ():. PubMed ID: 38233319
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
[TBL] [Abstract][Full Text] [Related]
8. Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach.
Rhee DJ; Beddar S; Jaoude JA; Sawakuchi G; Martin R; Perles L; Yu C; He Y; Court LE; Ludmir EB; Koong AC; Das P; Koay EJ; Taniguichi C; Niedzielski JS
Adv Radiat Oncol; 2023; 8(4):101164. PubMed ID: 36798731
[TBL] [Abstract][Full Text] [Related]
9. Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer.
Mittauer KE; Yarlagadda S; Bryant JM; Bassiri N; Romaguera T; Gomez AG; Herrera R; Kotecha R; Mehta MP; Gutierrez AN; Chuong MD
Radiother Oncol; 2023 Nov; 188():109869. PubMed ID: 37657726
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
Henke LE; Olsen JR; Contreras JA; Curcuru A; DeWees TA; Green OL; Michalski J; Mutic S; Roach MC; Bradley JD; Parikh PJ; Kashani R; Robinson CG
Adv Radiat Oncol; 2019; 4(1):201-209. PubMed ID: 30706029
[TBL] [Abstract][Full Text] [Related]
11. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
[TBL] [Abstract][Full Text] [Related]
13. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
14. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
15. Improved Ipsilateral Breast and Chest Wall Sparing With MR-Guided 3-fraction Accelerated Partial Breast Irradiation: A Dosimetric Study Comparing MR-Linac and CT-Linac Plans.
Musunuru HB; Yadav P; Olson SJ; Anderson BM
Adv Radiat Oncol; 2021; 6(3):100654. PubMed ID: 34195491
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
17. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
18. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.
Zhang Y; Chiu T; Dubas J; Tian Z; Lee P; Gu X; Yan Y; Sher D; Timmerman R; Zhao B
Radiat Oncol; 2019 Nov; 14(1):193. PubMed ID: 31684993
[TBL] [Abstract][Full Text] [Related]
19. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
[TBL] [Abstract][Full Text] [Related]
20. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
